Cargando…

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?

Detalles Bibliográficos
Autor principal: Chandler, Rebecca E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688196/
https://www.ncbi.nlm.nih.gov/pubmed/28856621
http://dx.doi.org/10.1007/s40264-017-0593-3
_version_ 1783279108020502528
author Chandler, Rebecca E.
author_facet Chandler, Rebecca E.
author_sort Chandler, Rebecca E.
collection PubMed
description
format Online
Article
Text
id pubmed-5688196
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-56881962017-11-30 Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient? Chandler, Rebecca E. Drug Saf Commentary Springer International Publishing 2017-08-30 2017 /pmc/articles/PMC5688196/ /pubmed/28856621 http://dx.doi.org/10.1007/s40264-017-0593-3 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Commentary
Chandler, Rebecca E.
Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
title Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
title_full Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
title_fullStr Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
title_full_unstemmed Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
title_short Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
title_sort safety concerns with hpv vaccines continue to linger: are current vaccine pharmacovigilance practices sufficient?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688196/
https://www.ncbi.nlm.nih.gov/pubmed/28856621
http://dx.doi.org/10.1007/s40264-017-0593-3
work_keys_str_mv AT chandlerrebeccae safetyconcernswithhpvvaccinescontinuetolingerarecurrentvaccinepharmacovigilancepracticessufficient